Seroprevalence of SARS-CoV-2 antibodies and reduced risk of reinfection through 6 months: a Danish observational cohort study of 44 000 healthcare workersSARS-CoV-2 항체의 혈청 유병률 및 6개월 동안 재감염 위험 감소: 44,000명의 의료 종사자를 대상으로 한 덴마크 관찰 코호트 연구Observational Study Published on 2022-05-012022-09-12 Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), MERS, SARS, 임상, 진단, [키워드] 95%CI acute respiratory syndrome antibody Characteristics coronavirus disease Coronavirus-2 COVID COVID-19 ELISA examined HCW HCWs healthcare worker Healthcare workers immune response increased risk infection with SARS-CoV-2 key factor longitudinal change majority Observational cohort study offered Older participant Prospective Study protective effect Questionnaires reduced risk Registered Reinfection remained reported risk risk ratio RRs SARS-CoV-2 SARS-CoV-2 antibody screened seropositive seropositive participants Seropositivity Seroprevalence significantly higher significantly increased significantly lower Symptom [DOI] 10.1016/j.cmi.2021.09.005 PMC 바로가기 [Article Type] Observational Study
Evaluation of Antibody Response to SARS-CoV-2 mRNA-1273 Vaccination in Patients With Cancer in Florida플로리다의 암 환자에서 SARS-CoV-2 mRNA-1273 백신 접종에 대한 항체 반응 평가Article Published on 2022-05-012022-09-12 Journal: JAMA Oncology [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] 95% CI age anti-CD20 anti-CD20 treatment antibody Antibody Response applied blood test calculated Cancer cancer diagnosis cancer type cohort study diagnose dose doses English enzyme-linked immunosorbent Factor geometric mean titer hematologic Hispanic IgG IgG level Immunosuppressive treatment individual lowest lymphocyte lymphoid monoclonal antibody treatment morbidity and mortality mRNA-1273 Older outcome participant Patient patients treated Patients with cancer receipt receiving response SARS-CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV-2 spike protein SARS-CoV-2 vaccine Seroconversion Seropositivity significantly lower small molecule solid tumor Spanish T Test treated Treatment vaccination vaccine dose vaccine response white [DOI] 10.1001/jamaoncol.2022.0001 PMC 바로가기 [Article Type] Article
The effect of a third BNT162b2 vaccine on breakthrough infections in health care workers: a cohort analysis의료 종사자의 돌발성 감염에 대한 세 번째 BNT162b2 백신의 효과: 코호트 분석Article Published on 2022-05-012022-09-11 Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 all age groups BNT162b2 BNT162b2 mRNA vaccine BNT162b2 vaccine booster booster dose Breakthrough infection breakthrough infections Care Cohort cohort analysis coronavirus coronavirus disease Coronavirus disease 2019 defined delta variant dose follow-up period HCW HCWs Health Health care Health care worker health care workers indicate infection rate infection rates infections initiated Jerusalem mass vaccination Ministry of Health protective effect Relative risk risk SARS-CoV-2 severe acute respiratory syndrome Coronavirus significantly lower third dose two-dose regimen vaccination Vaccine vaccine dose variant [DOI] 10.1016/j.cmi.2022.01.019 PMC 바로가기 [Article Type] Article
Regdanvimab in patients with mild-to-moderate SARS-CoV-2 infection: A propensity score-matched retrospective cohort study경증에서 중등도의 SARS-CoV-2 감염 환자의 레그단비맙: 성향 점수 일치 후향적 코호트 연구Article Published on 2022-05-012022-09-12 Journal: International immunopharmacology [Category] COVID19(2023년), SARS, 진단, [키워드] age analyses Analysis applied Clinical efficacy Comorbidities Control control groups COVID-19 CT-P59 Day death disease disease severity Efficacy evaluated high risk Mild-to-moderate neutralizing antibody outcome Patient patients with COVID-19 patients with moderate Pneumonia potential benefit primary endpoint Propensity score proportion PSM reduced reducing reduction regdanvimab required retrospective cohort study risk Safety SARS-CoV-2 SARS-COV-2 infection severe disease significantly significantly lower supplemental oxygen Therapies therapy treated Treatment utility [DOI] 10.1016/j.intimp.2022.108570 PMC 바로가기 [Article Type] Article
Assessing the impact of COVID-19 at 1-year using the SF-12 questionnaire: Data from the Anticipate longitudinal cohort studyObservational Study Published on 2022-05-012022-10-04 Journal: International Journal of Infectious Diseases [Category] 임상, [키워드] addition Assessing baseline can be used Cohort COVID COVID-19 COVID-19 in patient Diagnosis enrolled female Follow-up form help identify IMPROVE initial Long COVID longitudinal cohort study Lower median Mental Observational cohort study participant Patient physical Post–COVID-19 Syndrome predict predictor Quality of life reduced risk SARS-CoV-2 SF-12 significantly significantly lower survey Symptom syndrome without symptom [DOI] 10.1016/j.ijid.2022.03.013 PMC 바로가기 [Article Type] Observational Study
Limited T cell response to SARS-CoV-2 mRNA vaccine among patients with cancer receiving different cancer treatments다른 암 치료를 받는 암 환자에서 SARS-CoV-2 mRNA 백신에 대한 제한된 T 세포 반응Article Published on 2022-05-012022-09-12 Journal: European journal of cancer (Oxford, England : 1990 [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] administration adverse event anti-S anti-S IgG blood sample Cancer cancer treatment CD4+ CD4+ T cell CD8+ CD8+ T cell cellular response Chemotherapy collected complement complications conducted control group COVID-19 COVID-19 case cut-off defined demonstrated determine develop diagnose dose driven by enrolled first dose follow-up period HCW Health care worker high risk humoral Humoral response Immunotherapy inhibitor involved kinase Limited magnitude mRNA vaccine mRNA-1273 mRNA-1273 vaccine Patient patient reported outcome Patients with cancer receiving reported SARS-CoV-2 second dose significantly higher significantly lower single-center study Solid solid tumour Solid tumours T cell response T cells treated vaccination Vaccine vaccine dose [DOI] 10.1016/j.ejca.2022.02.017 PMC 바로가기 [Article Type] Article
The expression patterns of MALAT-1, NEAT-1, THRIL, and miR-155-5p in the acute to the post-acute phase of COVID-19 diseaseCOVID-19 질병의 급성기에서 후기 급성기 MALAT1, NEAT1, THRILL 및 miR-155-5p의 발현 패턴Article Published on 2022-05-012022-09-11 Journal: The Brazilian journal of infectious diseases : an [Category] COVID19(2023년), SARS, 바이오마커, 진단, [키워드] acute COVID-19 acute phase addition Analysis Biomarker COVID-19 COVID-19 diagnosis COVID-19 disease COVID-19 infection diagnose diagnosis of COVID-19 disease evaluated expression level expression levels expression pattern expression patterns hallmark hallmarks healthy control healthy individual Infection Inflammation Inflammatory factor inflammatory factors Long Long non-coding RNAs MicroRNAs miR-150 miR-155 MONITOR mononuclear cell ncRNA ncRNAs non-coding RNA Non-coding RNAs Pathogenesis pathogenesis of COVID-19 Patient PBMC peripheral Peripheral blood real-time PCR assay RNA ROC Curve selected severity of COVID-19 significantly increased significantly lower the SARS-CoV-2 THRIL Total total RNA [DOI] 10.1016/j.bjid.2022.102354 PMC 바로가기 [Article Type] Article
Effect of montelukast therapy on clinical course, pulmonary function, and mortality in patients with COVID-19몬테루카스트 요법이 COVID-19 환자의 임상 경과, 폐 기능 및 사망률에 미치는 영향Randomized Controlled Trial Published on 2022-05-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, 임상, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Admission affected Anti-inflammatory C-reactive protein Chain Reaction China Clinical course coronavirus coronavirus disease COVID-19 COVID-19 patient COVID-19 patients D-dimer Day delta variant determine diagnosed Effect Effectiveness Effects expiratory Expiratory flow fibrinogen forced expiratory volume forced vital capacity group hospital Hospitalized improvement Infection Infectious disease Infectious diseases laboratory parameter Laboratory parameters Lactate lactate dehydrogenase maintain Montelukast Mortality nasopharyngeal swabs national guideline national guidelines not differ parameter Patient patients patients with COVID-19 peak expiratory flow polymerase chain polymerase chain reaction Prevent procalcitonin Pulmonary function Pulmonary function test Pulmonary function tests randomized controlled study real-time polymerase chain reaction reduce mortality Respiratory failure SARS-CoV-2 severe acute respiratory syndrome Coronavirus significantly lower standard treatment therapy three group three groups Treatment variant of SARS-CoV-2 vital capacity Volume [DOI] 10.1002/jmv.27552 PMC 바로가기 [Article Type] Randomized Controlled Trial
Effect of the Mindfulness-Based Stress Reduction program on stress, anxiety, and childbirth fear in pregnant women diagnosed with COVID-19Randomized Controlled Trial Published on 2022-05-012022-10-05 Journal: Complementary therapies in clinical practice [Category] 임상, [키워드] Anxiety Attitude BAI Beck Childbirth collected composed control group COVID-19 diagnosed with COVID-19 distress Effect Effectiveness eight experimental group Health IMPROVE inventory material Mental mindfulness Perinatal Perinatal mental health Pregnancy pregnant women Prenatal mood. professional provided Psychological well-being randomized-controlled reduce significantly lower Stress the mean Trial was performed [DOI] 10.1016/j.ctcp.2022.101566 PMC 바로가기 [Article Type] Randomized Controlled Trial
Bi-ECDAQ: An electrochemical dual-immuno-biosensor accompanied by a customized bi-potentiostat for clinical detection of SARS-CoV-2 Nucleocapsid proteinsBi-ECDAQ: SARS-CoV-2 뉴클레오캡시드 단백질의 임상 검출을 위한 맞춤형 이중-전위기(bi-potentiostat)와 함께 제공되는 전기화학적 이중 면역 바이오센서Article Published on 2022-05-012022-09-11 Journal: Biosensors & bioelectronics [Category] COVID19(2023년), SARS, 치료기술, 치료법, [키워드] accompanied acquisition active site active sites All-in-one data acquisition platform approach Bi-potentiostat readout system carboxyl comparable complex COVID-19 COVID-19 patient Data acquisition diagnostics Diseases Dual working screen-printed electrode Electrochemical immunosensing eliminating flexible functional incompatible lack limit of detection matrix effect N-protein Nasopharyngeal swab nasopharyngeal swab sample nucleocapsid protein offered performed point-of-care Protein Recognition resulting SARS-CoV-2 SARS-CoV-2 nucleocapsid SARS-CoV-2 nucleocapsid protein Screen sensitive assay sensitivity significantly lower unmet need [DOI] 10.1016/j.bios.2022.114018 PMC 바로가기 [Article Type] Article